Physician profile
Andre Dean Graham
NPI 1376525253
$16,915.08
in general payments reported to CMS, 2019-2025
15 companies · $571 in 2025
The $571 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,234 · 2022: $178 · 2023: $9,690 · 2024: $3,242 · 2025: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,750 · Travel and Lodging: $3,240 · Food and Beverage: $2,489 · Gift: $23.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,750.00 |
| Travel and Lodging | $3,240.17 |
| Food and Beverage | $2,489.23 |
| Gift | $23.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,058.74 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Orthofix Medical, INC. | $222.17 | 2025 | Truelok |
| Tela Bio, INC. | $217.28 | 2022-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Amarin Pharma, INC. | $68.16 | 2019 | |
| Polynovo North America LLC | $59.69 | 2024 | Novosorb Btm |
| Innovation Technologies INC | $58.10 | 2023 | Irrisept |
| Davol INC. | $45.93 | 2024 | Phasix Mesh |
| Integra Lifesciences Corporation | $33.01 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medtronic, INC. | $30.80 | 2025 | Pteye Parathyroid Detection System |
| Molnlycke Health Care US, LLC | $30.26 | 2024 | Mepilex Border Post-Op Ag, Avance |
| Depuy Synthes Sales INC. | $27.30 | 2024 | |
| Baxter Healthcare | $25.27 | 2025 | Perclot |
| Covidien LP | $16.26 | 2019 | |
| Endo Pharmaceuticals INC. | $12.61 | 2019 | |
| Kerecis Limited | $9.50 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.